| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-06 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.18 | 6e-06 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.19 | 0.0002 |